Studies have shown that the RTEL1 genomic locus is often amplified in human cancers [21, 88, 89] and the polymorphisms of this gene are associated with several cancers, including gliomas, neuroblastoma, lung, and breast cancer [19, 20, 90, 91]. This evidence concerns the gene RTEL1 and central nervous system cancer.